Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Network meta-analysis of eribulin versus other chemotherapies used as second- or later-line treatment in locally advanced or metastatic breast cancer

Fig. 4

Network Diagram: Progression-free Survival (Base-case Analysis). Abbreviations: CAP = capecitabine; ERI = eribulin; GEM = gemcitabine; IXA = ixabepilone; TPC = treatment by physician’s choice; UTI = utidelone; VIN = vinorelbine

Back to article page